What CytoAgents' new $2M grant from NIH will help the biotech firm do By: Pittsburgh Business Times via Business Journals March 10, 2021 at 13:33 PM EST The company's drug candidate treats a deadly complication of Covid-19 and other respiratory illnesses. Read More >>